[1] |
Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary[J]. Crit Pathw Cardiol, 2005, 4(4):198-203.
|
[2] |
Nejatinamini S, Ataie-Jafari A, Qorbani M, et al. Asso-ciation between serum uric acid level and metabolic syndrome components[J]. J Diabetes Metab Disord, 2015, 14:70.
|
[3] |
Fu CC, Wu DA, Wang JH, et al. Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chinese type 2 diabetic patients[J]. Acta Diabetol, 2009, 46(2):127-134.
|
[4] |
Guo L, Cheng Y, Wang X, et al. Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality[J]. Acta Diabetol, 2012, 49(Suppl 1):S65-S71.
|
[5] |
Mankovsky B, Kurashvili R, Sadikot. Is serum uric acid a risk factor for atherosclerotic cardiovascular disease? A review of theclinical evidence. Part 1. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 4, 2010:176-184.
|
[6] |
Gersch C, Palii SP, Kim KM, et al. Inactivation of nitric oxide by uric acid[J]. Nucleosides Nucleotides Nucleic Acids, 2008, 27(8):967-978.
|
[7] |
Norvik JV, Storhaug HM, Ytrehus K, et al. Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study[J]. BMC Cardiovasc Disord, 2016, 16:85.
|
[8] |
Culleton BF, Larson MG, Evans JC, et al. Prevalence and correlates of elevated serum creatinine levels: the Framin-gham Heart Study[J]. Arch Intern Med, 1999, 159(15):1785-1790.
|
[9] |
Coresh J, Wei GL, McQuillan G, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey(1988-1994)[J]. Arch Intern Med, 2001, 161(9):1207-1216.
|
[10] |
Muntner P, He J, Hamm L, et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States[J]. J Am Soc Nephrol, 2002, 13(3):745-753.
|
[11] |
Al-Daghri NM, Al-Attas OS, Wani K, et al. Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Saudi Type 2 Diabetic Patients[J]. Sci Rep, 2017, 7(1):12104.
|
[12] |
Kim ES, Kwon HS, Ahn CW, et al. Serum uric acid level is associated with metabolic syndrome and microalbumi-nuria in Korean patients with type 2 diabetes mellitus[J]. J Diabetes Complications, 2011, 25(5):309-313.
|
[13] |
Sah SK, Khatiwada S, Pandey S, et al. Association of high-sensitivity C-reactive protein and uric acid with the metabolic syndrome components[J]. Springerplus, 2016, 5:269.
|
[14] |
Gu L, Huang L, Wu H, et al, R. Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disea-se in type 2 diabetes mellitus patients with preserved kidney function[J]. Diab Vasc Dis Res, 2017, 14(3):221-225.
|
[15] |
Vincent MA, Barrett EJ, Lindner JR, et al. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin[J]. Am J Physiol Endocrinol Metab, 2003, 285(1):E123-E129.
|
[16] |
Heinig M, Johnson RJ. Role of uric acid in hypertension, renal disease, and metabolic syndrome[J]. Cleve Clin J Med, 2006, 73(12):1059-1064.
|
[17] |
Kaur J. A comprehensive review on metabolic syndrome[J]. Cardiol Res Pract, 2014, 2014:943162.
|
[18] |
Kawamoto R, Tabara Y, Kohara K, et al. Usefulness of combining serum uric acid and high-sensitivity C-reactive protein for risk stratification of patients with metabolic syndrome in community-dwelling women[J]. Endocrine, 2013, 44(1):132-139.
|
[19] |
Krishnan E, Kwoh CK, Schumacher HR, et al. Hyperu-ricemia and incidence of hypertension among men without metabolic syndrome[J]. Hypertension, 2007, 49(2):298-303.
|
[20] |
Matsuura F, Yamashita S, Nakamura T, et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity[J]. Metabolism, 1998, 47(8):929-933.
|
[21] |
Schmidt MI, Watson RL, Duncan BB, et al. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators[J]. Metabolism, 1996, 45(6):699-706.
|
[22] |
Eräranta A, Kurra V, Tahvanainen AM, et al. Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency[J]. J Hypertens, 2008, 26(8):1661-1668.
|
[23] |
Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk[J]. N Engl J Med, 2008, 359(17):1811-1821.
|
[24] |
Facchini F, Chen YD, Hollenbeck CB, et al. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration[J]. JAMA, 1991, 266(21):3008-3011.
|